Provided by Tiger Fintech (Singapore) Pte. Ltd.

CANBRIDGE-B

2.150
-0.140-6.11%
Volume:3.79M
Turnover:8.27M
Market Cap:1.10B
PE:-1.89
High:2.300
Open:2.280
Low:2.130
Close:2.290
52wk High:3.100
52wk Low:0.095
Shares:511.00M
HK Float Shares:511.00M
Volume Ratio:1.80
T/O Rate:0.74%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.136
ROE:-281.91%
ROA:-57.53%
PB:-2.46
PE(LYR):-1.89
PS:16.11

Loading ...

CANBRIDGE-B (01228) Completes Issuance of 9.996 Million Shares, Raising Approximately HK$22.59 Million

Stock News
·
Sep 28

Canbridge Pharmaceuticals Announces Completion of Private Placement, Raising HK$22.6 Million Through New Share Subscription

Reuters
·
Sep 28

HK Movers | Biotech Shares Soar. CANbridge up 6%; WuXi XDC up 5%; WuXi Biologics, Ascletis, Hengrui Pharma up 3%

Tiger Newspress
·
Sep 22

BRIEF-CANbridge Pharmaceuticals Inc To Issue 10 Million Shares At HK$2.26 Per Share

Reuters
·
Sep 15

CANBRIDGE-B (01228) Plans to Issue 9.996 Million Shares at 19.86% Discount, Raising Net Proceeds of HK$22.09 Million

Stock News
·
Sep 15

Canbridge Pharmaceuticals Inc. Announces Subscription Agreements for Issuance of 9,996,196 New Shares at HK$2.26 Each

Reuters
·
Sep 15

CANbridge Pharmaceuticals Inc - to Issue 10 Mln Shares at HK$2.26 per Share

THOMSON REUTERS
·
Sep 15

CANBRIDGE-B (01228) Shareholder Deposits Shares Worth HK$218 Million into PUYIN International Securities

Stock News
·
Sep 11

Hong Kong Stocks Movement | CANBRIDGE-B (01228) Surges Over 19% Again, Cumulative Gains Exceed 20-fold This Year as Three Products Pass Initial Review for Commercial Insurance Innovative Drug Directory

Stock News
·
Sep 08

Hong Kong Stock Alert | CANBRIDGE-B (01228) Surges Over 9%, Annual Cumulative Gain Reaches 16-fold as Company Achieves Turnaround to Profitability in First Half

Stock News
·
Sep 05

Canbridge Pharmaceuticals Inc. Releases Supplemental Announcement on Audited 2024 Financial Results

Reuters
·
Sep 03

Stock Track | CANbridge Pharmaceuticals Soars Nearly 16% on Return to Profitability in H1 2025

Stock Track
·
Sep 01

CANbridge Pharmaceuticals Returns to Profitability in H1; Shares Up 13%

MT Newswires Live
·
Sep 01

CANBRIDGE-B (01228) Reports Interim Results with Profit of RMB 59.238 Million, Turning from Loss to Profit Year-over-Year

Stock News
·
Aug 31

CANbridge Pharmaceuticals H1 Adjusted Net Income RMB -37.4 Million

THOMSON REUTERS
·
Aug 31

CANbridge Pharmaceuticals H1 Gross Margin 69.3%

THOMSON REUTERS
·
Aug 31

CANbridge Pharmaceuticals H1 Revenue RMB 22.2 Million

THOMSON REUTERS
·
Aug 31

CANBRIDGE-B (01228) Issues 74.97 Million Shares on August 27 Under Subscription Agreement

Stock News
·
Aug 27

CANBRIDGE-B (01228) Appoints Wang Tingwei as Non-Executive Director and Nomination Committee Member

Stock News
·
Aug 27

HK Movers | Biotech Stocks Decline, Clover Biopharmaceuticals Drops Over 14%

Tiger Newspress
·
Aug 27